Zol0b 0023 01
Zoledronic Acid Injection, Solution
Product Images NDC 25021-830
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 25021-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zol0b 0023 02
Zol0b 0023 03
Zoledronic Acid Injection is a medication that contains 5mg of zoledronic acid monohydrate per 100mL bag. It is used for intravenous infusion and should not be mixed with calcium-containing solutions. The infusion time should be no less than 15 minutes. Each bag should only be used once, and the unused portion should be discarded. In addition to zoledronic acid, each bag contains mannitol, sodium citrate, and water for injection. It should be administered as a single intravenous solution through a separate infusion line. The medication should be stored at a temperature between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). The container closure is not made with natural rubber latex. A medication guide should be provided to each patient, and the medication is sterile, nonpyrogenic, preservative-free, DEHP-free, and PVC-free.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
